Switching strategy improves overall survival in breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1550, 2006-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel regimen improves survival in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Trastuzumab improves survival in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

TAC regimen improves survival in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Switching to adjuvant exemestane after tamoxifen improves disease-free survival in postmenopausal women with hormone receptor-positive early breast cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Uracil/tegafur improves survival in node-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite